Cited 22 times in
Retinal Hemorrhage after SARS-CoV-2 Vaccination
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김성수 | - |
dc.contributor.author | 김용준 | - |
dc.contributor.author | 박효송 | - |
dc.contributor.author | 변석호 | - |
dc.contributor.author | 이승규 | - |
dc.date.accessioned | 2022-02-23T01:04:01Z | - |
dc.date.available | 2022-02-23T01:04:01Z | - |
dc.date.issued | 2021-12 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/187522 | - |
dc.description.abstract | To report retinal vein occlusion (RVO) and age-related macular degeneration (AMD)-related submacular hemorrhage developing after administration of SARS-CoV-2 vaccines, a single-center, retrospective observational case series was conducted. Clinical data including fundus photographs and optical coherence tomography (OCT) scans were reviewed. Twenty-three eyes of 21 patients were included with the median age at symptom presentation being 77 years (range: 51-85 years). Twelve eyes (52.2%) had submacular hemorrhage and 11 (47.8%) had RVO. Twelve patients (60.9%) had been vaccinated with the Pfizer vaccine (BNT162b2) and 8 with the AstraZeneca (ChAdOx1) vaccine. Sixteen patients (76.2%) experienced ocular disease exacerbation after the first vaccination and 4 (19.0%) after the second vaccination. The median visual acuity (logarithm of the minimal angle of resolution; logMAR) before symptom development was 0.76 (interquartile range: 0.27-1.23); the median logMAR at symptom presentation was 1.40 (interquartile range 0.52-1.70). The median time between vaccination and symptom exacerbation was 2.0 days (interquartile range: 1.0-3.0 days). Five patients (23.8%) underwent tests for hematological abnormalities, including the presence of anti-PF4 antibodies; all were negative. Further studies with larger patient group for evaluation of effect of SARS-CoV-2 vaccination on retinal hemorrhage are necessary. | - |
dc.description.statementOfResponsibility | open | - |
dc.language | English | - |
dc.publisher | MDPI AG | - |
dc.relation.isPartOf | JOURNAL OF CLINICAL MEDICINE | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.title | Retinal Hemorrhage after SARS-CoV-2 Vaccination | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Ophthalmology (안과학교실) | - |
dc.contributor.googleauthor | Hyo Song Park | - |
dc.contributor.googleauthor | Yeojue Byun | - |
dc.contributor.googleauthor | Suk Ho Byeon | - |
dc.contributor.googleauthor | Sung Soo Kim | - |
dc.contributor.googleauthor | Yong Joon Kim | - |
dc.contributor.googleauthor | Christopher Seungkyu Lee | - |
dc.identifier.doi | 10.3390/jcm10235705 | - |
dc.contributor.localId | A00571 | - |
dc.contributor.localId | A05821 | - |
dc.contributor.localId | A06049 | - |
dc.contributor.localId | A01849 | - |
dc.contributor.localId | A02913 | - |
dc.relation.journalcode | J03556 | - |
dc.identifier.eissn | 2077-0383 | - |
dc.identifier.pmid | 34884407 | - |
dc.subject.keyword | BNT162b2 | - |
dc.subject.keyword | ChAdOx1 nCoV-19 | - |
dc.subject.keyword | SARS-CoV-2 | - |
dc.subject.keyword | retinal vein occlusion | - |
dc.subject.keyword | submacular hemorrhage | - |
dc.subject.keyword | vaccine | - |
dc.contributor.alternativeName | Kim, Sung Soo | - |
dc.contributor.affiliatedAuthor | 김성수 | - |
dc.contributor.affiliatedAuthor | 김용준 | - |
dc.contributor.affiliatedAuthor | 박효송 | - |
dc.contributor.affiliatedAuthor | 변석호 | - |
dc.contributor.affiliatedAuthor | 이승규 | - |
dc.citation.volume | 10 | - |
dc.citation.number | 23 | - |
dc.citation.startPage | 5705 | - |
dc.identifier.bibliographicCitation | JOURNAL OF CLINICAL MEDICINE, Vol.10(23) : 5705, 2021-12 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.